DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Tumor Ablation Market Size & Forecast By Technology, By Treatment, By Application And Trend Analysis From 2015 To 2022" report to their offering.
The global tumor ablation market is expected to reach USD 1.5 billion by 2022. The rising prevalence of different forms of cancer and increasing technological advancements in the field of thermal ablation techniques are the most prominent drivers of the market.
Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry.
Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone.
In terms of technological advancement, companies such as SonaCare Medical are coupling ablation techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable physicians to enhance patient care experience, thereby promoting market growth.
According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.
- Medtronic Plc.
- Mermaid Medical
- Galil Medical Inc.
- EDAP TMS S.A.
- Boston Scientific Corporation
- SonaCare Medical
- Misonix, Inc.
- Neuwave Medical, Inc.
Key Topics Covered:
1. Methodology and Scope
2. Executive Summary
3. Tumor Ablation Devices Industry Outlook
4. Tumor Ablation Devices Technology Outlook
5. Tumor Ablation Devices Treatment Outlook
6. Tumor Ablation Devices Application Outlook
7. Tumor Ablation Devices Regional Outlook
8. Competitive Landscape
For more information visit http://www.researchandmarkets.com/research/j8ln7k/tumor_ablation